findmyKOL
Clinical trialNCT00083603CompletedPhase 1Interventional

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment150HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety of and immune response to two HIV vaccine formulations, rMVA-HIV and rFPV-HIV, alone and in combination, in HIV uninfected adults.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Brazil
  • Projeto Praça Onze/hesfa Crs

    Rio de Janeiro, Brazil

  • Sao Paulo Hvtu - Crt Dst/aids Crs

    São Paulo, Brazil

United States
  • Alabama Vaccine Crs

    Birmingham, Alabama, United States

  • Saint Louis Univ. School of Medicine, Hvtu

    St Louis, Missouri, United States

  • Univ. of Rochester Hvtn Crs

    Rochester, New York, United States

  • Fhcrc/uw Vaccine Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Empty TBC-FPVTBC-MVA and TBC-FPVRFPV-HIVRMVA-HIV
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2004
Primary completion
—
Completion
31 Aug 2007
Last update posted
14 Oct 2021
Registered enrollment
150
Registry id
NCT00083603

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.